Stevanato Group S.p.A. Overview
Pro stress-test →Stevanato Group is a global leader in pharmaceutical drug containment, drug delivery, and diagnostic solutions with a 75-year heritage. The company serves biopharma, biotech, and life sciences companies by providing integrated solutions across the entire drug lifecycle, from development through commercial stages.
Strategic Profile
Pro stress-test →Stevanato leverages deep expertise in precision glass manufacturing combined with cutting-edge engineering to provide value-added solutions for injectable biologics and biosimilars. The company is strategically positioned around high-value solutions (now representing 49% of revenue), with significant capacity expansion underway at Latina and Fishers facilities to capitalize on growing demand for self-administration and ready-to-use drug platforms.
Competitive Landscape
Pro stress-test →Stevanato competes in the pharmaceutical packaging and drug delivery ecosystem against specialized competitors including West Pharmaceutical Services (prefillable syringes), SCHOTT Pharma (glass containers), and Pro-Dex (engineering services). Stevanato's competitive advantage lies in its integrated end-to-end portfolio spanning containment, delivery systems, diagnostics, and manufacturing services across multiple segments, allowing customers single-source solutions.
Industry Context
Stevanato Group S.p.A. operates in Pharmaceutical Packaging & Drug Delivery Systems.
Key facts
Founded: 1949 · Headquarters: Piombino Dese, Italy · Revenue: €1.17B · Market cap: $4.37B